Home
Venrock Healthcare Capital Partners III reported a 2.8% stake in Enliven Therapeutics ELVN · 1,726,331 sh · amendment · passive holder
Trade details
- Type
- 5% stake report
- Report
- 13G passive · amendment
- Stake
- 2.8%
- Last report
- 5.4% · filed 25/11/14
- Shares held
- 1,726,331 sh
- Class
- Common Stock, $0.001 par value per share
- Event date
- 26/03/31
- Filed
- 26/05/15
2.8% stake · below 5%
- Stake
- 2.8%
- Last report
- 5.4%
- Since last report
- −2.6pp
Enliven Therapeutics trades, last 26 weeks
What else happened in Enliven Therapeutics around then
Filed or reported within 30 days of the trade day · 03/01~04/30Venrock Healthcare Capital Partners III's other 5% stake reports
- Venrock Healthcare Capital Partners III
5% stakeX4 Pharmaceuticals
5% stakeX4 Pharmaceuticals
XFOR
5.6% stake
5,555,047 sh
5.6% stake
Filed 09/21
- Venrock Healthcare Capital Partners III
5% stakeKorsana Biosciences
5% stakeKorsana Biosciences
KRSA
9.9% stake
4,552,277 sh
9.9% stake
Filed 09/15
- Venrock Healthcare Capital Partners III
5% stakeTenax Therapeutics
5% stakeTenax Therapeutics
TENX
4.7% stake
1,574,892 sh
4.7% stake
Filed 08/14
- Venrock Healthcare Capital Partners III
5% stakeOruka Therapeutics
5% stakeOruka Therapeutics
ORKA
7.4% stake
4,556,952 sh
7.4% stake
Filed 08/14
- Venrock Healthcare Capital Partners III
5% stakeJade Biosciences
5% stakeJade Biosciences
JBIO
8.3% stake
5,145,330 sh
8.3% stake
Filed 08/14
